Podcasts about fda commissioner scott gottlieb

Pink Sheet reporter and editors discuss the issues and concerns raised during a major generic industry conference (:42), former FDA Commissioner Scott Gottlieb's views on what a second Trump term as president would mean for the agency (13:54), and congressional hearings on FDA foreign manufacturing facility inspections and drug shortages (23:51). More On These Topics From The Pink Sheet ‘We Did Too Good Of A Job' On Lowering Prices: Sandoz's Haruvi Discusses Generic Sustainability: https://pink.citeline.com/PS149745/We-Did-Too-Good-Of-A-Job-On-Lowering-Prices-Sandozs-Haruvi-Discusses-Generic-Sustainability Blue Shield Of California's Pharmacy Benefit Overhaul Could Still See Boost From Transparency Legislation: https://pink.citeline.com/PS149751/Blue-Shield-Of-Californias-Pharmacy-Benefit-Overhaul-Could-Still-See-Boost-From-Transparency-Legislation Gottlieb: FDA Would Be Subject To More White House Control Under A Second Trump Term: https://pink.citeline.com/PS149737/Gottlieb-FDA-Would-Be-Subject-To-More-White-House-Control-Under-A-Second-Trump-Term Congress Explores Plans For Catching Up On US FDA Foreign Inspections: https://pink.citeline.com/PS149744/Congress-Explores-Plans-For-Catching-Up-On-US-FDA-Foreign-Inspections Environmental Regulations May Create Barriers To Onshoring More Rx Manufacturing: https://pink.citeline.com/PS149749/Environmental-Regulations-May-Create-Barriers-To-Onshoring-More-Rx-Manufacturing

Today we look at jerks who hurt their dogs to get pain pills then we dive deep into the conspiracy known as “Project Blue Beam.” Vote For Your Favorite Paranormal Podcast: Dead Rabbit Radio! https://paranormalitymag.com/vote25/ Patreon https://www.patreon.com/user?u=18482113 PayPal Donation Link https://tinyurl.com/mrxe36ph MERCH STORE!!! https://tinyurl.com/y8zam4o2 Amazon Wish List https://www.amazon.com/hz/wishlist/ls/28CIOGSFRUXAD?ref_=wl_share Dead Rabbit Radio Wiki https://deadrabbitradio.pods.monster/doku.php?id=Welcome Help Promote Dead Rabbit! Dual Flyer https://i.imgur.com/OhuoI2v.jpg "As Above" Flyer https://i.imgur.com/yobMtUp.jpg “Alien Flyer” By TVP VT U https://imgur.com/gallery/aPN1Fnw “QR Code Flyer” by Finn https://imgur.com/a/aYYUMAh Links: Statement by FDA Commissioner Scott Gottlieb, M.D., on the FDA's new resource guide to support responsible opioid prescribing for pain management in animals https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm617007.htm People deliberately harm pets to get prescriptions for opioids https://www.channel3000.com/lifestyle/pets/people-deliberately-harm-pets-to-get-prescriptions-for-opioids/780290475 People deliberately harm pets to get prescriptions for opioids https://kdvr.com/2018/08/09/people-deliberately-harm-pets-to-get-prescriptions-for-opioids/ Hurting Pets to Get Attention and Drugs: A Growing Problem https://www.psychologytoday.com/us/blog/animals-and-us/201808/hurting-pets-get-attention-and-drugs-growing-problem Study: People are harming pets to get opioids https://www.wishtv.com/national/study-people-are-harming-pets-to-get-opioids/1361157026 Beware Pets, Your Owners May Be Using You To Get Opioids, Warns FDA https://www.forbes.com/sites/brucelee/2018/08/18/beware-pets-your-owners-may-be-using-you-to-get-opioids/#10419f244938 Serge Monast's Project Blue Beam Makes Today's Conspiracy Theories Look Sane https://allthatsinteresting.com/project-blue-beam-serge-monast Project Blue Beam https://rationalwiki.org/wiki/Project_Blue_Beam Serge Monast https://en.wikipedia.org/wiki/Serge_Monast MATTERS OF DEEP CONCERN TO US ALL http://www.despatch.cth.com.au/Despatch/vol91_Concern.html NASA Blue Beam Project https://www.bibliotecapleyades.net/sociopolitica/esp_sociopol_bluebeam01.htm Project Blue Beam: NASA Is Beta Testing Alien Invasion https://www.disclose.tv/project-blue-beam-nasa-is-beta-testing-alien-invasion-314751 Nighttime Rocket Launch To Create Colorful Clouds in Space https://www.nasa.gov/feature/wallops/2017/nasa-sounding-rocket-will-release-early-morning-artificial-clouds0lighting-up-the-mid-atlantic-coast-may-31 Terrier-Improved Malemute Launch: Vapor deployment test https://www.youtube.com/watch?v=eRbFCOYpXEo Devil's Due (Star Trek: The Next Generation) https://en.wikipedia.org/wiki/Devil%27s_Due_(Star_Trek:_The_Next_Generation)  ------------------------------------------------ Logo Art By Ash Black Opening Song: "Atlantis Attacks" Closing Song: "Bella Royale" Music By Simple Rabbitron 3000 created by Eerbud Thanks to Chris K, Founder Of The Golden Rabbit Brigade Dead Rabbit Archivist Some Weirdo On Twitter AKA Jack YouTube Champ Stewart Meatball The Haunted Mic Arm provided by Chyme Chili The Golden Rabbit Army: Fabio N, Chyme Chili, Greg Gourley, Vixen Wiki created by Germ http://www.DeadRabbit.com Email: DeadRabbitRadio@gmail.com Twitter: @DeadRabbitRadio Facebook: www.Facebook.com/DeadRabbitRadio TikTok: https://www.tiktok.com/@deadrabbitradio Dead Rabbit Radio Subreddit: https://www.reddit.com/r/DeadRabbitRadio/ Paranormal News Subreddit: https://www.reddit.com/r/ParanormalNews/ Mailing Address Jason Carpenter PO Box 1363 Hood River, OR 97031 Paranormal, Conspiracy, and True Crime news as it happens! Jason Carpenter breaks the stories they'll be talking about tomorrow, assuming the world doesn't end today. All Contents Of This Podcast Copyright Jason Carpenter 2018 - 2023  

Clips of media hypocrisy on Biden-Trump classified documents. Clay and Buck open up the C&B VIP mailbag. Investigative journalist and author Alex Berenson joins Clay and Buck to discuss how he joined Elon Musk's Twitter Files team and what the files say about former FDA Commissioner Scott Gottlieb. C&B on rock bands.Follow Clay & Buck on YouTube: https://www.youtube.com/c/clayandbuckSee omnystudio.com/listener for privacy information.

This week on "Face the Nation," with Russian forces moving forward with a brutal assault on Eastern Ukraine, we talk to White House national security adviser Jake Sullivan about what more the U.S. can do to help. Then, a conversation with former FDA Commissioner Scott Gottlieb about a possible spring COVID surge. Joining the program is Cleveland Fed President Loretta Mester to discuss rising costs in the U.S. And finally Former Homeland Security Secretary Jeh Johnson on the crisis at the southern border.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Former Food and Drug Administration Commissioner Scott Gottlieb joins Dr. Marc Siegel and discusses the FDA's speed of approvals for vaccines and therapeutics, the disappointing level of uptake of COVID19 vaccines for kids, how home testing has changed the paradigm for consumer self-diagnoses, and what steps we should take moving forward.

Andy digs into the latest science behind Omicron with former FDA Commissioner Scott Gottlieb. They discuss what we know about the origin of Omicron, how it's likely to play out in the US, and if we'll need an Omicron-specific vaccine. It's still early, but Andy and Scott have you covered with the most up-to-date information out there about this new variant and the risk it poses.    Keep up with Andy on Twitter @ASlavitt and Instagram @andyslavitt.    Follow Scott @ScottGottliebMD on Twitter.   Joining Lemonada Premium is a great way to support our show and get bonus content. Subscribe today at bit.ly/lemonadapremium.    Support the show by checking out our sponsors!   Click this link for a list of current sponsors and discount codes for this show and all Lemonada shows: https://lemonadamedia.com/sponsors/  Throughout the pandemic, CVS Health has been there, bringing quality, affordable health care closer to home—so it's never out of reach for anyone. 

Learn more at cvshealth.com.   Check out these resources from today's episode:    Watch Dr. Fauci's full interview about Omicron on State of the Nation: https://www.cnn.com/videos/politics/2021/12/05/fauci-full-12-5.cnn   Learn more about the Omicron outbreak in Tshwane, South Africa, as mentioned by Scott: https://www.samrc.ac.za/news/tshwane-district-omicron-variant-patient-profile-early-features Read more on the coming oral antivirals from Merck and Pfizer and what they mean with Omicron looming: https://www.nytimes.com/2021/12/07/science/merck-pfizer-covid-pill-treatment.html Check out Scott's book, Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic: https://www.harpercollins.com/products/uncontrolled-spread-scott-gottlieb?variant=39344420356130 Find a COVID-19 vaccine site near you: https://www.vaccines.gov/  Order Andy's book, Preventable: The Inside Story of How Leadership Failures, Politics, and Selfishness Doomed the U.S. Coronavirus Response: https://us.macmillan.com/books/9781250770165    Stay up to date with us on Twitter, Facebook, and Instagram at @LemonadaMedia.    For additional resources, information, and a transcript of the episode, visit lemonadamedia.com/show/inthebubble. See omnystudio.com/listener for privacy information.

Throughout the COVID-19 pandemic, former FDA Commissioner Scott Gottlieb, M.D., has been one of the most visible commentators on the public health crisis. His insights and writings have helped shaped some of the country's understanding of the public health impacts of the pandemic since early in 2020. As the country continues to battle the pandemic—especially the emergent delta variant of the coronavirus—Gottlieb will visit the Club for the first time to discuss his new book, Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic. Gottlieb's new book outlines how the United States must prepare for future pandemics by learning from the mistakes made handling the COVID-19 outbreak, which has caused one of the greatest public health tragedies in American history. Gottlieb outlines his efforts in the early 2000s to develop a “Pandemic Influenza Plan” to ready the United States for the threat of a global pandemic, and how short the country came up when it was time to mount an effective response to the novel coronavirus. Further, Gottlieb identifies the early reasons why the United States was so underprepared for the pandemic, from failing to enlist the private sector in large-scale manufacturing of testing supplies and medical equipment to resolutely sticking to the narrative that COVID would go away on its own. As the United States heads into a critically important fall and winter that will determine whether we will finally end the pandemic, Gottlieb's book comes at a critical time. Please join us for a timely talk with a true expert on the pandemic about what we have learned so far, and what we must do to succeed in the months and years ahead. SPEAKERS Scott Gottlieb M.D., Former Commissioner, Food and Drug Administration; Resident Fellow, American Enterprise Institute; Author, Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic Mark Zitter Chair, The Zetema Project; Member, Commonwealth Club Board of Governors—Moderator In response to the COVID-19 pandemic, we are currently hosting all of our live programming via YouTube live stream. This program was recorded via video conference on October 5th, 2021 by the Commonwealth Club of California. Learn more about your ad choices. Visit megaphone.fm/adchoices

Throughout the COVID-19 pandemic, former FDA Commissioner Scott Gottlieb, M.D., has been one of the most visible commentators on the public health crisis. His insights and writings have helped shaped some of the country's understanding of the public health impacts of the pandemic since early in 2020. As the country continues to battle the pandemic—especially the emergent delta variant of the coronavirus—Gottlieb will visit the Club for the first time to discuss his new book, Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic. Gottlieb's new book outlines how the United States must prepare for future pandemics by learning from the mistakes made handling the COVID-19 outbreak, which has caused one of the greatest public health tragedies in American history. Gottlieb outlines his efforts in the early 2000s to develop a “Pandemic Influenza Plan” to ready the United States for the threat of a global pandemic, and how short the country came up when it was time to mount an effective response to the novel coronavirus. Further, Gottlieb identifies the early reasons why the United States was so underprepared for the pandemic, from failing to enlist the private sector in large-scale manufacturing of testing supplies and medical equipment to resolutely sticking to the narrative that COVID would go away on its own. As the United States heads into a critically important fall and winter that will determine whether we will finally end the pandemic, Gottlieb's book comes at a critical time. Please join us for a timely talk with a true expert on the pandemic about what we have learned so far, and what we must do to succeed in the months and years ahead. SPEAKERS Scott Gottlieb M.D., Former Commissioner, Food and Drug Administration; Resident Fellow, American Enterprise Institute; Author, Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic Mark Zitter Chair, The Zetema Project; Member, Commonwealth Club Board of Governors—Moderator In response to the COVID-19 pandemic, we are currently hosting all of our live programming via YouTube live stream. This program was recorded via video conference on October 5th, 2021 by the Commonwealth Club of California. Learn more about your ad choices. Visit megaphone.fm/adchoices

Congress is back in session with a short time to finish a long to-do list, including keeping the government operating and paying its bills. Hanging in the balance is President Joe Biden's entire domestic agenda, including major changes proposed for Medicare, Medicaid and the Affordable Care Act. Meanwhile, the new Texas abortion law that bans the procedure early in pregnancy is prompting action in Washington. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Sarah Karlin-Smith of the Pink Sheet join KHN's Julie Rovner to discuss these issues and more. Also, Rovner interviews former FDA Commissioner Scott Gottlieb about his new book on the covid-19 pandemic.

First, STAT's Helen Branswell joins us to discuss the state of the Covid-19 pandemic as we head into another winter. Then, former FDA Commissioner Scott Gottlieb calls in to discuss his new book on how the U.S. got caught off guard and what the government needs to do before the next pandemic hits. We start with a look at the latest news in the life sciences, including the booster debate, Biogen's trouble selling its controversial Alzheimer's drug, and the awkward pairing of beer and face masks.

Former FDA Commissioner Dr. Scott Gottlieb gives an inside account of the system wide failure across the U.S. government that left the country blind amidst the global covid pandemic. Throughout the pandemic, he was in regular contact with all the key players in the government and the drug and diagnostic companies. Find out how we can better prepare for the next health crisis – be it a deadlier covid variant, a flu pandemic, or a man-made biological threat. Scott is the author of Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic.

On today's podcast, former FDA Commissioner Scott Gottlieb joins host Charlie Sykes to discuss his new book: "Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic." (https://www.amazon.com/Preparing-Inevitable-Normal-Survive-Epidemic/dp/006308001X) Special Guest: Scott Gottlieb.

STAT's Andrew Joseph joins us to talk about the two-year anniversary of the approval of gene therapy Zolgensma and the effect it has had on families dealing with the rare disease spinal muscular atrophy. Then, former FDA Commissioner Scott Gottlieb calls in with tips on Memorial Day grilling, notes on a recent Twitter spat, and thoughts on the origins of SARS-CoV-2.

Mark Strassmann reports the latest on the recovery efforts in Texas, Plus interviews with Fort Wayne Mayor Betsy Price, and Houston Mayor Sylvester Turner on how their cities are coping with the winter blast. We'll hear from former White House deputy national security adviser, Matt Pottinger, for his insight on the Trump administration's response to COVID-19, the virus' origins and more. As the global community doubles-down on its commitment to vaccine access this week, what needs to happen next? We'll hear from former FDA Commissioner Scott Gottlieb. All this and more on this week's "Face the Nation."

Dr. Scott Gottlieb, former FDA commissioner and a current Pfizer board member, shares his thoughts on the COVID-19 vaccine distribution and supply successes and challenges, potential drug pricing legislation, and the future of the ACA. At the center of the conversation? The employer role.

On this week's "Face the Nation," the race to vaccinate and the challenges of new COVID strains. What do states need to fight the virus and protect Americans? Moderator Margaret Brennan speaks with former FDA Commissioner Scott Gottlieb, Connecticut Governor Ned Lamont, and Miami's Mayor Francis Suarez. We'll also hear from President Joe Biden's Senior Advisor Cedric Richmond and Chicago School's CEO Janice Jackson, about the President's plan to re-open schools. Plus -- CBS News Foreign Correspondent Ramy Inocencio travels back to Wuhan, China -- one year after he visited the city the coronavirus was first reported.

The long wait -- as a COVID-19 vaccine roll out continues -- but why is it taking so long to get the shots to most Americans? We talk to Operation Warp Speed's chief adviser Moncef Slaoui as well as former FDA Commissioner Scott Gottlieb. We'll hear from Los Angeles Mayor Eric Garcetti about the surge in coronavirus cases in LA. Meanwhile, Republican Senator Asa Hutchinson of Arkansas says nearly 1/4 of the Senate GOP plans to challenge President-Elect Biden's 2020 win. Moderator Margaret Brennan will have all that and more on this week's "Face the Nation."

As many travel on Thanksgiving weekend, experts warn of a surge in coronavirus cases. We hear from White House COVID-19 task Force coordinator Deborah Birx, and former FDA Commissioner Scott Gottlieb. We'll have interviews with Detroit Mayor Mike Duggan, and El Paso Mayor Dee Margo, about the rising cases in their cities. Plus, we'll hear from "Feeding America's" Clarie Babineaux-Fontenot, and World Food Programme chief David Beasley about feeding the nation’s hungry over the holidays. These stories on this week's "Face the Nation."

Election Night 2020 is just 48 hours away -- as coronavirus cases continue to rise across the country. We'll hear from former DHS Chair Jeh Johnson, former FDA Commissioner Scott Gottlieb, GOP Chair Ronna McDaniel, and Florida Rep. Val Demings. Plus -- Moderator Margaret Brennan talks to CBS News' election night team ahead of the historic election. All that and more on this week's "Face the Nation."

Countdown to Election Day and concerns about voting in a pandemic. We'll have the latest coronavirus numbers with former FDA Commissioner Scott Gottlieb and the latest polls for CBS Elections and Surveys Director Anthony Salvanto. Plus -- an exclusive interview with Regeneron's CEO, Leonard Schleifer. about President Trump's coronavirus treatment. All this and more on this week's "Face the Nation."

President Trump tests positive for COVID-19. We'll have a new CBS News Battleground Tracker Poll AND talk to voters about how the most recent news will impact the election. Plus interviews with House Speaker Nancy Pelosi, LabCorps. CEO Adam Schechter, former FDA Commissioner Scott Gottlieb, and National Security Adviser Robert O'Brien and more on this week's "Face the Nation."

On Saturday, President Donald Trump announced that he will nominate Judge Amy Coney Barrett to the Supreme Court, to fill the vacant seat left by Justice Ruth Bader Ginsburg. We'll get reactions from Former White House Counsel Don McGahn, Senator Chris Coons (D-DE), and White House Chief of Staff Mark Meadows. Former United States Secretary of Homeland Security Jeh Johnson weighs in on election security and the ongoing controversy surrounding the death of Breonna Taylor. We'll get the latest coronavirus numbers from former FDA Commissioner Scott Gottlieb. Plus, a new CBS News Battleground Tracker Poll with Elections and Surveys director Anthony Salvanto. These stories and more on this week's "Face the Nation."

On this week's "Face the Nation," we look back on the life and legacy of Supreme Court Justice Ruth Bader Ginsburg, who died Friday at the age of 87. We'll discuss what the vacancy means for the upcoming election. We'll hear from Senator Cory Booker (D-NJ) and Senator Roy Blunt (R-MO) for reactions from both sides of the aisle, AND former President Bill Clinton. Plus -- we'll have the latest coronavirus numbers with former FDA Commissioner Scott Gottlieb, and discuss ensuring voter's safety come Election Day.

If this pandemic plays out like a baseball game, former FDA Commissioner Scott Gottlieb says we're only in the second inning. He joins CNBC's Tyler Mathisen and Meg Tirrell to talk testing, vaccines, and what we're still learning about the virus.

Dr. Scott Gottlieb is the former commissioner of the Food and Drug Administration and resident fellow at the American Enterprise Institute, where he continues his work on improving public health through entrepreneurship and medical innovation and on expanding regulatory approaches to maintain patient and physician autonomy.  We talked about regulatory approaches to making prescription drugs more affordable. Learn why price controls, like those which would be implemented in the Democrats’ drug pricing bill HR3, have terrible consequences for the development and innovation of prescription drugs.

This Friday’s podcast is vehicles and vapes. Tesla’s new truck isn’t exactly what it was cracked up to be, Uber’s major shareholders are making moves, and vaping industry executives are meeting with President Trump at the White House. On today’s episode: CNBC reporters Eunice Yoon and Phil LeBeau, Wedbush Securities’ Dan Ives, Tusk Ventures’ Bradley Tusk, Columbia Business School’s Craig Hatkoff, and Fmr. FDA Commissioner Scott Gottlieb. Learn more about your ad choices. Visit megaphone.fm/adchoices

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast. This week, the top managed care news included CMS Administrator Seema Verma calling for more disruption to the healthcare system; former FDA Commissioner Scott Gottlieb, MD, reflecting on the agency’s record of innovation; liraglutide demonstrating promise for youth with type 2 diabetes. Read more about the stories in this podcast: CMS' Verma: Upend the Status Quo to Move to Value-Based Care: https://www.ajmc.com/conferences/naacos-spring-2019/cms-verma-upend-the-status-quo-to-move-to-valuebased-care National Association of ACOs Spring 2019: https://www.ajmc.com/conferences/naacos-spring-2019 In First Speech Since Stepping Down as FDA Commissioner, Gottlieb Reflects on Agency's Push for Innovation: https://www.ajmc.com/conferences/whcc-2019/in-first-speech-since-stepping-down-as-fda-commissioner-gottlieb-reflects-on-agencys-push-for-innovation World Health Care Congress 2019: https://www.ajmc.com/conferences/whcc-2019 Liraglutide Lowers A1C in Youth With Type 2 Diabetes, Phase 3 Study Finds: https://www.ajmc.com/focus-of-the-week/liraglutide-lowers-a1c-in-youth-with-type-2-diabetes-phase-3-study-finds/ Study: Oncotype DX-Guided Treatment May Cut Breast Cancer Care Costs by $50 Million in US: https://www.ajmc.com/newsroom/study-oncotype-dxguided-treatment-may-cut-breast-cancer-care-costs-by-50-million-in-us Why Patients Seek Out Medical Cannabis: https://www.ajmc.com/managed-care-cast/why-patients-seek-out-medical-cannabis

The second installment of Ropes & Gray's new podcast series, Non-binding Guidance, addresses the departure of former FDA Commissioner Scott Gottlieb, who resigned from his position last month. During his time at FDA, Commissioner Gottlieb employed an ambitious policy agenda, taking significant steps to combat the opioid crisis, improve access to generic drugs and biosimilars, confront the use of e-cigarettes by minors, and more. In this episode, Ropes & Gray lawyers Greg Levine, Kellie Combs, and Beth Weinman explore several areas of uncertainty that remain in the wake of Dr. Gottlieb's resignation: the regulation of laboratory developed tests, dietary supplements, and off-label communications. Tune in to this discussion to learn more about the unfinished business of the Gottlieb administration, the impact of his resignation, and how the agency will move forward under Acting Commissioner Ned Sharpless.

This week’s regulatory compliance updates are from April 1 to April 8 and contain information for California, Colorado, Michigan, and Washington dispensaries, as well as federal and international news. California is being sued by 24 cities over a rule that allows marijuana deliveries in places that have banned cannabis retail stores. A Los Angeles Times article noted “Those that stand to benefit from the state rules allowing home deliveries include 311 state-licensed delivery firms.” The Colorado Sunset Bill “Proposes Changes for Pot Industry Rules and Regulations”, including (but not limited to) selling hemp and CBD in recreational dispensaries with testing, medical marijuana equivalency limits for patients, and merging medical and retail marijuana codes. In Michigan, Metrc released information within a recent bulletin on a new software update that will allow Provisioning Centers the ability to record sales deliveries to a qualifying patient. As of April 5, 2019, the Metrc Admin for each Provisioning Center will see a new selectable “Deliveries” option beneath the “Sales” tab. Michigan regulators also released an updated “Home Deliveries Procedures Checklist” for medical cannabis deliveries. This extensive 3-page checklist will help ensure all home deliveries are compliant with the regulations. In Washington state, the WSLCB shared that they will soon seek input from cannabis testing labs, as well as retailers, on upcoming Quality Assurance Testing and Product Requirements. Also, Leaf Data Systems’ newest version will include numeric standardization that will standardize decimal values pertaining to weights and the replacement of drop-down menus with “type-ahead” search fields for batches, inventories and inventory types. Soon after, Qlik reports are scheduled to be available. In federal and international news... On April 2nd, the FDA Commissioner Scott Gottlieb issued a press release on hemp and hemp-derived cannabidiol (also referred to as “Hemp CBD”). The FDA is creating a “working group” to “explore potential pathways for dietary supplements and/or conventional foods containing CBD to be lawfully marketed.” Guam became the first U.S. jurisdiction to legalize marijuana in 2019 with the signature of Gov. Lou Leon Guerrero (D) on April 4th. When it goes into effect, the U.S. territory’s new law will permit adults 21 and older to possess and grow cannabis, and it will create a system of licensed and regulated businesses to produce and sell marijuana. That concludes this week’s regulatory compliance updates. For more information, please visit greenbits.com/blog.

Lone Jespersen is principal of Cultivate, an organization dedicated to helping food manufacturers globally make safe, great tasting food through cultural effectiveness. Lone has significant experience with food manufacturing, having previously spent 11 years with Maple Leaf Foods. Following the tragic event in 2008 when Maple Leaf products claimed 23 Canadian lives, Lone lead the execution of the Maple Leaf Foods, food safety strategy, and its operations learning strategy.  Prior to that, Lone worked for Woodbridge Foam as the engineering and operations manager responsible for the safety and quality of automobile safety products. Lone holds a Master's degree in mechanical engineering from Syd Dansk University, Denmark, and a Master's of food science and a Ph.D. from the University of Guelph, Canada. Mike Robach is chairman of the GFSI board. Up until August 2018, he served as the vice president, corporate food safety, quality, & regulatory for Cargill based in Minneapolis, MN. Prior to joining Cargill, he headed up technical services for Conti Group’s meat and poultry businesses, and began his career with Monsanto. Mike is the past president of Safe Supply of Affordable Food Everywhere, a member of the Scientific and Regulatory Affairs Council Executive Committee for the Grocery Manufacturers Association, and a member of the U.S. Poultry and Egg Association’s Research Advisory Committee. Mike has worked with the World Organization of Animal Health and the Food and Agriculture Organization on harmonized animal health and food safety standards. He has worked closely with the U.S. Department of Agriculture and the U.S. Food and Drug Administration regarding food safety policy, Hazard Analysis and Critical Control Points, and regulatory reforms based on science. From 1995 through 2000, Mike was a member of the National Advisory Committee for Microbiological Criteria in Foods. Mike is a graduate of Michigan State University and Virginia Tech. Frank Yiannas is the U.S. Food and Drug Administration's (FDA) Deputy Commissioner for Food Policy and Response, a position he assumed in December 2018. He is the principal advisor to FDA Commissioner Scott Gottlieb in the development and execution of policies related to food safety, including implementation of the landmark FDA Food Safety Modernization Act. His leadership role within the agency covers a broad spectrum of food safety priorities, such as outbreak response, traceback investigations, product recall activities, and supply chain innovation across the full spectrum of FDA-regulated products. Prior to joining FDA, Frank was the vice president of food safety at Walmart—the world's largest food retailer. In that role, Frank oversaw all food safety—as well as other public health functions—for Walmart, serving over 200 million customers around the world on a weekly basis. His scope of responsibilities included food safety oversight of Walmart’s stores, Neighborhood Markets, and Sam’s Clubs. He was also charged with training and education of associates, food safety oversight of thousands of food suppliers, and a number of critical regulatory compliance issues. Prior to joining Walmart in 2008, Frank was the director of safety and health for The Walt Disney Company, where he worked for 19 years. In 2001, under his tenure, Walt Disney World received the prestigious Black Pearl Award for corporate excellence in food safety by the International Association for Food Protection (IAFP). Frank is a registered microbiologist with the American Academy of Microbiology and holds memberships with several professional associations. Frank received his B.Sc. in Microbiology from the University of Central Florida and his Master's of Public Health from the University of South Florida. In this episode of Food Safety Matters, we speak to Frank [15:07], and Lone and Mike [25:08] about: Highlights, key moments, and takeaways from this year's GFSI conference in Nice, France The value of networking, collaborating, sharing challenges, and learning best practices at GFSI Projects that GFSI is working on with various government entities, the private sector, academia, and consumers The Global Markets Program GFSI's continuous improvement in the areas of benchmarking requirements, technology, certification programs, and capacity building The emerging trend of e-commerce as a food safety topic to watch Produce safety as a global issue, not just a North American issue GFSI's partnerships with STOP Foodborne Illness and Pew Charitable Trusts GFSI's unique position as the industry's premier place to bring together food industry professionals from all cultures and backgrounds Improvements that can be made around how food safety performance is measured Working in the retail/private vs. regulatory sectors Government's continuously improving response to foodborne illness outbreaks FDA's future use of blockchain technology and spreading the idea of food safety culture Related Content  A Culture of Food Safety: A Position Paper from GFSI News Mentioned in This Episode Leafy Greens Industry Working on New Water Guidelines; LGMA announcement  [4:12] Emails Show FDA Worry After Romaine Outbreaks  [0:00] USDA to Audit Brazil's Meat Inspections After 2017 Import Ban; Brazil's announcement  [8:02] FDA Requests Funds for More High-Tech, Digital Food Safety System; FDA statement [12:47] Sponsor:  Downloads: Recall Readiness: Lessons Learned & A Look Ahead  Food Safety & Traceability Software Buyer's Guide   ​ Visit Foodlogiq.com to request a demo Keep Up with Food Safety Magazine Follow Us on Twitter @FoodSafetyMag and on Facebook  Subscribe to our magazine and our biweekly eNewsletter We Want to Hear From You! Please share your comments, questions, and suggestions. Tell us about yourself—we'd love to hear about your food safety challenges and successes. We want to get to you know you! Here are a few ways to be in touch with us: Email us at podcast@foodsafetymagazine.com Record a voice memo on your phone and email it to us at podcast@foodsafetymagazine.com

In this episode of Mike on Medtech with Mike Drues, president of Vascular Sciences, we discuss the FDA’s letter from March 15, which provided a statement from FDA Commissioner Scott Gottlieb, M.D., and Jeffrey Shuren, M.D., Director of the Center for Devices and Radiological Health, on efforts to evaluate materials in medical devices to address potential safety questions. Specifically, we address a number of questions, including: What were the main contents of this announcement with regard to the evaluation of materials by the FDA? Are there certain materials they are expected to target early in this review process? What are technology-specific guidances and how do they relate to this effort? Will the FDA ban specific materials if they do not meet a certain criteria or have too high an incidence of reactions among patients? Will this effort ultimately lead to a regulatory pathway to approve materials for medical device manufacture? Does having a review process for materials that would be approved for use in medical devices run counter to allowing for a broad selection of materials for a given device and ultimately limit options for innovation?Listen to the podcast streaming via the player or get the podcast on the Medtech Matters channel via your preferred vendor of podcasts, such as Apple Podcasts (iTunes) or Spotify. Once you’ve had a chance to listen to the podcast, if you have any questions or comments you’d like us to discuss or share with other Mike on Medtech listeners about this topic or any other topic we’ve addressed, or you have a suggestion for a future topic for us to cover, email me at sfenske@rodmanmedia.com and we’ll try to respond in an upcoming Mike on Medtech podcast.

Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast. This week, the top managed care news included the Department of Justice siding with a federal judge in striking down the Affordable Care Act; FDA Commissioner Scott Gottlieb, MD, calling for stricter oversight of electronic health records; and a study finding that healthy eating in Medicare and Medicaid is cost effective. Read more about the stories in this podcast: DOJ Reverses Course, Sides With Judge Striking Down ACA: https://www.ajmc.com/focus-of-the-week/doj-reverses-course-sides-with-judge-striking-down-aca House Democrats Unveil Bill Aimed at Shoring Up ACA Patient Protections, Affordability: https://www.ajmc.com/newsroom/house-democrats-unveil-bill-aimed-at-shoring-up-aca-patient-protections-affordability What We're Reading: EHR Oversight; Medicaid Expansion and CRC; Arkansas Work Requirements: https://www.ajmc.com/newsroom/what-were-reading-ehr-oversight-medicaid-expansion-and-crc-arkansas-work-requirements In Scott Gottlieb's Final Weeks as FDA Commissioner, Tying Up Loose Ends: https://www.ajmc.com/focus-of-the-week/in-scott-gottliebs-final-weeks-as-fda-commissioner-tying-up-loose-ends Incentivizing Healthy Eating in Medicare, Medicaid Is Cost Effective, Study Finds: https://www.ajmc.com/focus-of-the-week/incentivizing-healthy-eating-in-medicare-medicaid-is-cost-effective-study-finds PD-L1 Testing "Name of the Game" in First-Line Treatment of NSCLC: https://www.ajmc.com/conferences/nccn-2019/pdl1-testing-name-of-the-game-in-firstline-treatment-of-nsclc National Comprehensive Cancer Network Annual Conference 2019: https://www.ajmc.com/conferences/nccn-2019 Keeping an Eye on Increasing Competition in the Specialty Drug Pipeline: https://www.ajmc.com/conferences/amcp-2019/keeping-an-eye-on-increasing-competition-in-the-specialty-drug-pipeline The Academy of Managed Care Pharmacy 2019: https://www.ajmc.com/conferences/amcp-2019

Ropes & Gray's new podcast series, Non-binding Guidance, highlights FDA regulatory developments and trends affecting the life sciences industry. In this inaugural episode, Ropes & Gray lawyers Al Cacozza, Sarah Blankstein and Joshua Oyster discuss how the FDA is currently regulating products containing cannabidiol, or CBD, and what to expect from FDA and Congress in the wake of FDA Commissioner Scott Gottlieb's surprise resignation this month. The 2018 Farm Bill, signed into law last December, legalized hemp and its non-psychoactive ingredient CBD and distinguished both from marijuana, which is still considered by the federal government to be an illegal narcotic. But the Farm Bill left a cloud of uncertainty hanging over the emerging CBD industry because it expressly allowed FDA to continue unchanged its oversight and regulation of CBD products. Tune in to this lively discussion of the repercussions of the Farm Bill, how the FDA and state agencies are responding, and what investors and other stakeholders should know.

FDA Commissioner Scott Gottlieb spoke at the Brookings Institution March 20 to talk about his departure from the agency. He noted that among the top issues that he hopes will be addressed after he leaves on April 5, are legislation addressing over-the-counter drugs and laboratory developed tests under a in-vitro clinical test bill known as the VALID Act.

Scott Gottlieb was nominated to run the FDA in March 2017. Two years — and nearly 500 press announcements — later, the productive and high-profile commissioner is preparing to step down in early April 2019. Gottlieb joined POLITICO's Dan Diamond to discuss why he's leaving FDA (starts at 1:30), his regulatory and communications strategy (4:40), his work on medical device safety (10:30), digital health (16:30), opioid abuse (19:15), the Trump administration's approach to science and the choice of Ned Sharpless as acting FDA commissioner (24:25), what Gottlieb would've pursued if he had more time at FDA (26:30) and if he'll ever return to government (28:30). MENTIONED ON THE SHOW As commissioner, Gottlieb has received bipartisan praise for his activist agenda. Gottlieb's aggressive moves as commissioner came as a surprise, given his pre-Trump administration reputation as someone with a free-market background. The conservative Washington Times cheered Gottlieb's departure, suggesting that he became "an avenging angel for the Nanny state" and pushed too much regulation on vaping. Before rejoining FDA in 2017, Gottlieb was a frequent critic of its actions, such as in a 2010 AEI column where Gottlieb urged FDA to become more transparent on drug company letters. Gottlieb steered numerous reforms at FDA, including pushing an overhaul of medical device reviews. FDA recently approved a powerful painkiller called Dsuvia, drawing some criticism. Gottlieb's January 2018 and November 2018 appearances on "Pulse Check."

One of the top US medical device lobbyists spoke to Medtech Insight about their work to extend a moratorium on the medical device excise tax and getting reimbursement for medical devices sooner. He commended FDA Commissioner Scott Gottlieb and their work to implement provisions in MDUFA IV.

Jeremy Zenlea is the director of corporate food safety at Cumberland Farms, Inc. In this role, he oversees all aspects of food safety, including regulatory compliance, retail and commissary food safety operations, and supply chain integrity. Jeremy has worked with a variety of different product categories, including refrigerated, high-risk ready-to-eat foods (meat, poultry, pork, and fresh-cut produce), chocolate, and confectionaries. Due to his diverse background, Jeremy has gained a wide range of knowledge of different food products and is an expert in constructing, implementing, and managing complex food safety and food defense systems for large domestic and international food manufacturers. He is an active member of both the Institute of Food Technologists and the International Association for Food Protection, and enjoys lecturing on food safety at local universities and mentoring other food safety professionals in his spare time. Jeremy received a B.Sc. from the University of Massachusetts-Amherst and an M.B.A from Northeastern University. In this episode of Food Safety Matters, we speak to Jeremy [11:49] about: What makes the convenience store environment different—and more complicated—than more traditional outlets that sell food Why having simple food safety procedures is a plus for all stakeholders Cold chain issues and temperature monitoring What he sees as the biggest threat to food safety in the convenience store setting The difficulties of training and certification for food safety professionals in convenience stores Turnover, foot traffic, and other challenges that convenience stores face Effective communication and establishing a positive food safety culture News Mentioned in This Episode FSAI Now Using New DNA Scanning Tool to Identify Food Ingredients [2:37]; FSAI press release  FDA Commissioner Scott Gottlieb to Resign [4:33]  California Must Abandon 535,000 Acres of Prized Farmland to Meet Water Conservation Goals [7:39]  Barbara's GFSI Recap [10:13] Keep Up with Food Safety Magazine Follow Us on Twitter @FoodSafetyMag and on Facebook  Subscribe to our magazine and our biweekly eNewsletter We Want to Hear From You! Please share your comments, questions, and suggestions. Tell us about yourself—we'd love to hear about your food safety challenges and successes. We want to get to you know you! Here are a few ways to be in touch with us. Email us at podcast@foodsafetymagazine.com Record a voice memo on your phone and email it to us at podcast@foodsafetymagazine.com

Show Description: In this episode, we recap the big current events from last week, including Elon Musk and his security clearance issues, the resignation of former FDA Commissioner Scott Gottlieb, NFL Prospect Shawn Oakman's road back to the NFL after a false crime accusation, and Mark Zuckerberg's war against information. We end the episode using body language to spot sincerity, as well as applying a future perspective mentality involving imagining yourself at your own funeral. Show Highlights: 4:00-10:30: We talk about Elon Musk's security clearance issues because of his Joe Rogan Podcast appearance 10:30-21:15: After former FDA Commissioner Scott Gottlieb's stance and actions on the dietary supplement tobacco industry, especially e-cigs and vapes, we discuss the possible meaning behind his resignation, and whether it was forced or not 21:15-31:15: We talk about NFL prospect Shawn Oakman, who went through a 3-year sexual assault trial for a crime he did not commit. We discuss the repercussions now for him as he pursues a possible NFL career, as well as our viewpoint on falsifying a crime 31:15-39:30: Mark Zuckerberg makes a big announcement about his quest to make more of our information secure on his platform. We talk about what this could mean for possible commerce and payment system for the platform, and whether this announcement was a political statement or not 39:30-46:30: Drawing from readings on body language, we get into how to tell when someone is lying, and looking at the difference between someone's words and emotional condition 46:30-53:00: We get into the future perspective mentality and imagining what your future funeral will look like. We reflect on what we can do to live a meaningful life in the present

The Enemies of Pleasure continue their push to make it harder to purchase cigars, FDA Commissioner Scott Gottlieb resigns, Democrats keep pushing to lower the voting age while raising the smoking age, Rep. Omar has gone after Obama and Dems will turn on her, naps help high blood pressure, plus a new cigar from Punch, new potato chips from Lays and a limited whiskey from Crown Royal.

This week, we talked with European Commission Trade Commissioner Cecilia Malmstrom about negotiating a trade deal between the EU and U.S. Dennis Purcell of Aisling Capital came on to discuss why the biotech sector was worried about the FDA Commissioner Scott Gottlieb's resignation. Jamie Montgomery of March Capital Partners joined from his namesake conference to talk about how the ongoing techlash was weighing on attendees. Then James Anderson,  partner and portfolio manager at Ballie Gifford, came to to discuss assessing his investment performance without benchmarks.

A 65 year old man shot an Amazon delivery driver after the delivery driver parked in a handicapped spot and then tried to beat the old man's ass for confronting him about it.  The old man then fled to a nearby Famous Foot Wear where he was apprehended by police, perhaps looking for a faster pair of shoes to escape with.A Sioux Falls, South Dakota High School is in some hot water after putting on the play “The Foreigner”  A play which featured many of the cast dressed in KKK garb, but does the play's positive message outweigh the racist costumes it requires?   You be the judge.FDA Commissioner Scott Gottlieb is resigning from his post citing he needs to spend more time with his family.  Sounds a little fishy, Scott.  In some good news though, a nasal spray form of Ketamine will soon be available to fight depression and put you in a government induced K Hole.  AWESOME!!And so much more in the ‘Lightning Round.'  If you have gotten this far in the blog you owe it to yourself to click the link to the podcast at the top and find out. 

FDA Commissioner Scott Gottlieb's leaving the Trump administration, and POLITICO reporters react to the monumental news. In the first panel (starts at the 1:30 mark), Sarah Karlin-Smith and Adam Cancryn join Dan Diamond to react to Gottlieb's resignation and discuss the political implications. In the second panel (starts at the 21:00 mark), Sarah Owermohle and Helena Bottemiller Evich join Dan to discuss Gottlieb's policies and reflect on his legacy. MENTIONED ON THE SHOW Gottlieb's appeared on PULSE CHECK twice: In January 2018, to discuss his agency's priorities, and November 2018, to unveil his e-cigarette strategy. POLITICO's Sarah, Sarah and Helena looked at Gottlieb's departure and key milestones. Bloomberg's Max Nisen argued that Gottlieb was the Trump administration's most popular official. The shutdown hit FDA especially hard, with Gottlieb and others warning that FDA's food safety inspections were imperiled.

Subscribe through iTunes and Google Play. Don’t Miss: Exclusive interview with FDA Commissioner Dr. Scott Gottlieb by ASCO CEO Dr. Clifford A. Hudis on the next ASCO in Action Podcast, coming January 29. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience and conclusions. The mention of any product, service, organization, activity or therapy should not be construed as an ASCO endorsement.  This is Cliff Hudis, CEO of the American Society of Clinical Oncology and host of the ASCO in Action podcast series. For our next podcast I will be speaking with Dr. Scott Gottlieb, Commissioner of the United States Food and Drug Administration. The FDA plays a critical role in delivery of high-quality cancer care by reviewing and approving new cancer treatments. This discussion is sure to be very interesting. It’s going to highlight what the FDA is doing to modernize clinical trials and expedite drug development, and with all of that I urge you to tune in for upcoming information about this special AiA podcast with Dr. Scott Gottlieb.  

Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast. This week, the top managed care news included a new investigation into drug prices; FDA Commissioner Scott Gottlieb, MD, provided updates on how the government shutdown is impacting FDA work; research found comorbidities impede clinical trial participation for patients with cancer. Read more about the stories in this podcast: Biologics, Diabetes, Cancer Drugs on House Oversight Probe List: https://www.ajmc.com/newsroom/biologics-diabetes-cancer-drugs-on-house-oversight-probe-list HHS Medicare Drug Shift Plan Could Reduce Costs Overall but Raise Them for Some, Researchers Say: https://www.ajmc.com/newsroom/hhs-medicare-drug-shift-plan-could-reduce-costs-overall-but-raise-them-for-some-researchers-say What We're Reading: FDA Resumes Some Inspections; Walmart Leaves CVS' PBM Networks; Flu Season: https://www.ajmc.com/newsroom/what-were-reading-fda-resumes-some-inspections-walmart-leaves-cvss-pbm-networks-flu-season Comorbidities Impede Clinical Trial Participation Among Patients With Cancer: https://www.ajmc.com/focus-of-the-week/comorbidities-impede-clinical-trial-participation-among-patients-with-cancer Understanding What Drives Health Information Exchange Use During Postacute Care Transitions: https://www.ajmc.com/managed-care-cast/understanding-what-drives-health-information-exchange-use-during-postacute-care-transitions The American Journal of Managed Care—January 2019, Health IT Issue: https://www.ajmc.com/journals/issue/2019/2019-vol25-n1

"I don't want anyone to think I'm against the harm-reduction potential of these devices for adults. But 3 percent of adults are using these devices — [and] 20 percent of high schoolers are using these devices." Surgeon General Jerome Adams sits down with POLITICO's Dan Diamond to explain why he's issuing an advisory on the risks of e-cigarettes for youth — just the second surgeon general advisory since 2005. (Starts at the 1:30 mark.) Adams also reviews what he thought of doctors' recent clash with the NRA on social media, how he's setting his 2019 priorities and even shares some personal details. After the break, POLITICO's Sarah Owermohle joins Dan to discuss Adams' comments on e-cigarettes and the Trump administration's broader push on vaping. (Starts at the 21:30 mark.) REFERENCED ON THE SHOW The surgeon general's office has a resource guide for parents, providers and children on e-cigarettes. FDA Commissioner Scott Gottlieb joined POLITICO's podcast in November to discuss his own concerns about vaping and his pending crackdown. Physicians pushed back after the NRA said doctors should "stay in their lane" and not discuss gun violence. Adams praised "Blue Zones," the work into why some communities appear to be healthier than others. Former Surgeon General Vivek Murthy appeared on POLITICO's "Pulse Check" in 2016, discussing his own approach to the role.

Today we look at jerks who hurt their dogs to get pain pills then we dive deep into the conspiracy known as “Project Blue Beam.”   A recent CDC report shows that people may be intentionally injuring their pets to get pain medication. How widespread is this problem and how can we stop it?   Then we look at an older, and previously more obscure, conspiracy theory known as “Project Blue Beam.” Did the governments of the world have a plan to destroy major religions via earthquakes and holograms? And a better question is: Could it actually work?   Statement by FDA Commissioner Scott Gottlieb, M.D., on the FDA’s new resource guide to support responsible opioid prescribing for pain management in animals https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm617007.htm   People deliberately harm pets to get prescriptions for opioids https://www.channel3000.com/lifestyle/pets/people-deliberately-harm-pets-to-get-prescriptions-for-opioids/780290475   People deliberately harm pets to get prescriptions for opioids https://kdvr.com/2018/08/09/people-deliberately-harm-pets-to-get-prescriptions-for-opioids/   Hurting Pets to Get Attention and Drugs: A Growing Problem https://www.psychologytoday.com/us/blog/animals-and-us/201808/hurting-pets-get-attention-and-drugs-growing-problem   Study: People are harming pets to get opioids https://www.wishtv.com/national/study-people-are-harming-pets-to-get-opioids/1361157026   Beware Pets, Your Owners May Be Using You To Get Opioids, Warns FDA https://www.forbes.com/sites/brucelee/2018/08/18/beware-pets-your-owners-may-be-using-you-to-get-opioids/#10419f244938   Serge Monast’s Project Blue Beam Makes Today’s Conspiracy Theories Look Sane https://allthatsinteresting.com/project-blue-beam-serge-monast   Project Blue Beam https://rationalwiki.org/wiki/Project_Blue_Beam   Serge Monast https://en.wikipedia.org/wiki/Serge_Monast   MATTERS OF DEEP CONCERN TO US ALL http://www.despatch.cth.com.au/Despatch/vol91_Concern.html   NASA Blue Beam Project https://www.bibliotecapleyades.net/sociopolitica/esp_sociopol_bluebeam01.htm   Project Blue Beam: NASA Is Beta Testing Alien Invasion https://www.disclose.tv/project-blue-beam-nasa-is-beta-testing-alien-invasion-314751   Nighttime Rocket Launch To Create Colorful Clouds in Space https://www.nasa.gov/feature/wallops/2017/nasa-sounding-rocket-will-release-early-morning-artificial-clouds0lighting-up-the-mid-atlantic-coast-may-31   Terrier-Improved Malemute Launch: Vapor deployment test https://www.youtube.com/watch?v=eRbFCOYpXEo   Devil's Due (Star Trek: The Next Generation) https://en.wikipedia.org/wiki/Devil%27s_Due_(Star_Trek:_The_Next_Generation)   Listen to the daily podcast anywhere you listen to podcasts!   ------------------------------------------------   Logo Art By Ash Black   "As Above" Art By Grant Scott   Intro Song: “Atlantis Attacks” Outro Song: “Bella Royale”   http://www.DeadRabbit.com Email: DeadRabbitRadio@gmail.com Twitter: @JasonOCarpenter Facebook: www.Facebook.com/DeadRabbitRadio   Paranormal, Conspiracy, and True Crime news as it happens! Jason Carpenter breaks the stories they'll be talking about tomorrow, assuming the world doesn't end today.   All Contents Of The Podcast Copyright Jason Carpenter 2018    

Show notes so you can follow along at home.Little Boy and Fat Man | Atomic Heritage FoundationPatriot (TV series) - WikipediaLetterkenny (TV series) - WikipediaBeastie Boys Book - Kindle edition by Michael Diamond, Adam HorovitzAmazon.com: Becoming eBook: Michelle ObamaBang (TV series) - WikipediaDid You Just Eat That? | W. W. Norton & CompanyDid You Just Eat That? Amazon.comAbout David LloydTour Dates | The Avett BrothersMay It Last: A Portrait of the Avett Brothers - Watch the HBO Original Documentary | HBOStan Lee - WikipediaStan Lee in ‘Mallrats,’ Kevin Smith’s Movie – Rolling StoneDo By FridayCTA drivers caught on video urinating, defecating on buses, face little actionBus driver was drunk, may have been drinking while driving, Melbourne police say | WFTVMystery high school pooper revealed as superintendent‘Super pooper’ suspect resigns Kenilworth post, demands $1M from policeHow good is liquor as a disinfectant? - QuoraDiscord server? : DoByFridayNever Home Alone: A Gala of Stories, Foods, and Insights from the Study of the Life in Homes Thu, Nov 15, 2018 at 7:00 PMNever Home Alone: From Microbes to Millipedes, Camel Crickets, and Honeybees, the Natural History of Where We Live, Rob Dunn - Amazon.comTechniques for the storage of human breast milk: implications for anti-microbial functions and safety of stored milk.Bactericidal activity of human milk: stability during storage.Cold storage of human milk: effect on its bacterial composition.Report of Neonatal Meningitis Due to Salmonella enterica Serotype Agona and Review of Breast Milk-Associated Neonatal Salmonella InfectionsMiso-Pickled Eggs Recipe - Nancy Singleton Hachisu | Food & WineEffect of miso soup containing Natto on the composition and metabolic activity of the human faecal floraEvaluation of the Bacteriological Safety of Low-Salt MisoStatement from FDA Commissioner Scott Gottlieb, M.D., on findings from the romaine lettuce E. coli O157:H7 outbreak investigation and FDA’s efforts to prevent future outbreaksEnvironmental Assessment of Factors Potentially Contributing to the Contamination of Romaine Lettuce Implicated in a Multi-State Outbreak of E. coli O157:H7Quantitative assessment of the microbial risk of leafy greens from farm to consumption: preliminary framework, data, and risk estimatesDuncan Hines Classic White, Classic Butter Golden, Signature Confetti and Classic Yellow Cake Mixes Recalled Due to Potential Presence of SalmonellaThe Dough Also Rises: The Reload | Good Eats: Reloaded | Cooking ChannelAn outbreak of Salmonella Typhimurium phage type 42 associated with the consumption of raw flourMultistate Outbreak of Salmonella Agbeni Infections Linked to Pet Turtles, 2017 (Final Update)Rare Salmonella Strain Sickened 8 in British Columbia Last Year | Food Safety NewsOutbreak of Salmonella Infections | Multistate Outbreak of Salmonella Agbeni Infections | November 2018Amazon.com : Duncan Hines Cake Mix, Classic White, 16.5 Ounce (Pack of 6) : Grocery & Gourmet FoodWarmMark 25°C/77°F Temperature Indicator (10-Pack)-WM 25/77-10PK - The Home Depot

FDA Commissioner Scott Gottlieb and director of the National Cancer Institute Norman E. “Ned” Sharpless discuss the latest advances and challenges in the field of oncology.

"All the great gains that we've made in this country, reducing smoking rates ... all of that will be reversed or lost if we can't address the youth use of e-cigarettes." FDA Commissioner Scott Gottlieb is planning a crackdown on sales of e-cigarettes — a story that broke on Thursday — and he sat down exclusively with POLITICO to talk about why the agency is making such a dramatic move. Gottlieb joined POLITICO's Dan Diamond to discuss his infamous "almonds don't lactate" comment and other nutrition news (starts at the 6:00 mark), explain his concerns about e-cigarettes and tease the FDA's pending crackdown (14:45), answer questions about the Trump administration's approach to science and vaccines (30:30), discuss FDA's new approach to approving opioids (35:30) and explain why the FDA's drug importation working group has been so low-profile (38:30). And stick around for the lightning round of questions about Gottlieb's job, which starts at 42:30. But first, POLITICO's Sarah Owermohle joins the podcast to put the e-cigarette news in context (starts at the 1:45 mark). MENTIONED ON THE PODCAST Gottlieb's infamous "an almond doesn't lactate" line at the POLITICO Pro summit. TV host Stephen Colbert touting "An Almond Doesn't Lacate" line of t-shirts. The FDA and Department of Agriculture's turf battle over lab-grown meat. Gottlieb's reported plan to crack down on sales of e-cigarettes. The fight over fetal tissue research inside HHS pitting "pro-life against pro-science." Concerns about President Trump's inaccurate comments about vaccines. FDA's formation of a working group to look at drug importation. Gottlieb's announcement of a new approach to opioid approvals.

In an administration proud of its deregulatory approach, FDA Commissioner Scott Gottlieb has defied the trend. He's proposed to mandate lower nicotine levels in cigarettes and suggested a willingness to crack down on electronic cigarette products popular with kids. Matthew L. Myers, president of the Campaign for Tobacco-Free Kids, and CQ health reporter Andrew Siddons assess the proposals and the likelihood Gottlieb will follow through.     Learn more about your ad choices. Visit megaphone.fm/adchoices

Teenage use of e-cigarettes has reached “an epidemic proportion,” the Food and Drug Administration said Wednesday, announcing that Juul and four other e-cigarette manufacturers have 60 days to “convincingly address” use by minors or the agency could take their products off the market. In a briefing, FDA Commissioner Scott Gottlieb said the companies failed to consider the public health impact of their products or their legal obligations.

The FDA has declared youth vaping an “epidemic of addiction” and is putting manufacturers of e-cigarettes on notice. FDA Commissioner Scott Gottlieb has given manufacturers of the top 5 brands of e-cigs 60 days to come up with new plans to prevent youth vaping or he might ban the sales of them all together. According to the latest numbers more than 2 million middle school, high school, and college students vape. Jayne O'Donnell, healthcare policy reporter for USA Today joins us for more on the epidemic use of e-cigs among teens. Next, it is a story that is getting national attention.  A murder of a beloved chef instructor was a mystery. Then Portland police arrested his romance novelist wife.  The big twist… she once penned an essay that was called, “How to murder your husband.” Shane Dixon Kavanaugh, reporter for the Oregonian, who first reported the story, joins us for details in this bizarre case. Finally, my producer Miranda joins us for more on this true crime story with a twist of irony and some of the oddest quotes from the Nancy Brophy essay, “How to murder your husband” Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast. This week in managed care, the top stories included HHS Secretary Alex Azar appearing before the Senate Committee on Finance to discuss the administration's plan to drive down prescription drug prices; FDA Commissioner Scott Gottlieb, MD, calling on payers to share data to aid drug innovation; and CMS calling for stricter oversight of Medicaid. Read more about the stories in this podcast: Azar Appears Before Senate Committee on Finance to Discuss Drug Innovation, Affordability: https://www.ajmc.com/focus-of-the-week/azar-appears-before-senate-committee-on-finance-to-discuss-drug-innovation-affordability Gottlieb Calls on Payers to Share Data to Aid Drug Innovation: https://www.ajmc.com/focus-of-the-week/gottlieb-calls-on-payers-to-share-data-to-aid-drug-innovation CMS Unveiling Stricter Oversight of Medicaid Due to Program Expansion: https://www.ajmc.com/newsroom/cms-unveiling-stricter-oversight-of-medicaid-due-to-program-expansion What We're Reading: SCOTUS Abortion Ruling; Use of HDHPs Grows; More Seniors Die at Home: https://www.ajmc.com/newsroom/what-were-reading-scotus-abortion-ruling-use-of-hdhps-grows-more-seniors-die-at-home Dr Robert A. Gabbay Highlights the Development of Joslin Diabetes Center's Clinical Guidelines: https://www.ajmc.com/interviews/dr-robert-a-gabbay-highlights-the-development-of-joslin-diabetes-centers-clinical-guidelines Evidence-Based Diabetes Management—June 2018: https://www.ajmc.com/journals/evidence-based-diabetes-management/2018/june-2018

On this week's podcast, Sue Darcey talks about some key takeaways from FDA Commissioner Scott Gottlieb's appearance at the Medical Device Manufacturers Association conference in Washington, DC, including some assurances on combination-product and pain-control-device reviews.

FDA Commissioner Scott Gottlieb announced this week that the FDA is seeking comment about reducing nicotine in combustible tobacco. He also previewed a future comment period about flavors and the impact they have on smoking, smoking cessation and youth im

FDA Commissioner Scott Gottlieb has been most effective, room for improvement, and what would make for a second successful year.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast. This week in managed care, the top stories included the announcement that Kentucky is the first state approved to require patients work to receive Medicaid benefits; FDA Commissioner Scott Gottlieb, MD, reveals a new program to improve clinical trial transparency; research finds the worst cases of attention-deficit/hyperactivity disorder could lower life expectancy. Read more about the stories in this podcast: Kentucky First State Approved for Medicaid Work Requirements: www.ajmc.com/newsroom/kentucky-first-state-approved-for-medicaid-work-requirements FDA Launches Pilot Program to Improve Transparency of Clinical Trial Information: www.ajmc.com/focus-of-the-week/fda-launches-pilot-program-to-improve-transparency-of-clinical-trial-information- FDA Approves Olaparib for Breast Cancer With a BRCA Gene Mutation: www.ajmc.com/newsroom/fda-approves-olaparib-for-breast-cancer-with-a-brca-gene-mutation Psychologist Barkley Says Life Expectancy Slashed in Worst Cases for Those With ADHD: www.ajmc.com/conferences/apsard-2018/psychologist-barkley-says-life-expectancy-slashed-in-worst-cases-for-those-with-adhd American Professional Society of ADHD and Related Disorders: www.ajmc.com/conferences/apsard-2018 January 2018 Health IT Issue: http://www.ajmc.com/journals/issue/2018/2018-vol24-n1

FDA’s influence can be summed up in a simple statistic: About 20 cents of every dollar that Americans spend is on a product — whether food, drug or tobacco — that’s regulated by the agency. But that enormous responsibility has also exposed the FDA to a broad array of critics, including President Donald Trump, who last year bashed the agency’s reviews as “slow and burdensome.” Trump’s pick to reform the agency? Commissioner Scott Gottlieb, who’s steered FDA since last May to the praise of conservatives — and, surprisingly in this political moment, some progressives who think he’s successfully balanced political pressures with public health priorities. Gottlieb joined POLITICO’s Dan Diamond to reflect on the agency’s 2017 achievements and why he joined the Trump administration (Starts at the 1:30 mark), the FDA’s nutrition policy and its role in keeping food safe (9:30), whether FDA is approving too many drugs (13:15), his to-do list for 2018 and looming policy priorities (19:00), the ongoing crisis in Puerto Rico and the effect on medical product development (22:10), how his role as a sometime-critic of FDA has squared with running the agency (25:45), FDA’s tobacco strategy (27:15), and a quick lightning round on Gottlieb’s infamous skinny jeans and other not-so-pressing questions (28:15). Then after the break, POLITICO senior food and agriculture reporter Helena Bottemiller Evich and pharma reporter Sarah Karlin-Smith analyze Gottlieb’s comments and discuss the looming challenges for the agency. (Starts at the 30:00 mark.) We’d appreciate your help: Please share PULSE CHECK and rate us on your favorite podcast app! Have questions, suggestions or feedback? Email ddiamond@politico.com. Stories referenced on the podcast: Matthew Herper’s review of Gottlieb’s top articles for Forbes: https://www.forbes.com/sites/matthewherper/2017/03/10/the-best-stories-scott-gottlieb-the-next-fda-commissioner-wrote-for-forbes/#5e1234d1c523 Gottlieb’s January 2016 article on the need for FDA to change its regulation of novel technologies: https://www.forbes.com/sites/scottgottlieb/2016/01/12/fda-needs-to-change-how-it-regulates-novel-technologies/#45a8b372191e Sarah’s look at what’s ahead for pharma in 2018: https://www.politico.com/newsletters/prescription-pulse/2018/01/03/pharma-weathers-storm-over-drug-prices-may-shift-tactics-062669 Helena’s article, “The Great Nutrient Collapse,” one of POLITICO’s most-read stories in 2017: https://www.politico.com/agenda/story/2017/09/13/food-nutrients-carbon-dioxide-000511

Earlier this month, the U.S. Food and Drug Administration announced a comprehensive policy framework for the development and oversight of regenerative medicine products. The framework spells out how the FDA intends to review new products and protect patient safety in this emerging area that FDA Commissioner Scott Gottlieb called “dynamic and complex” with “unique challenges.” We spoke to Michael Werner, executive director of the Alliance for Regenerative Medicine, about the framework, whether it provides the clarity industry sought, and what it will mean for patients hoping to see safe and effective regenerative therapies reach them as quickly as possible.

Episode 78 of BevNET’s Taste Radio podcast features a conversation with Chris Hunter, the co-founder of plant-based protein drink brand Koia and a co-founder of Phusion Projects, the Chicago-based alcoholic beverage company best known as the maker of Four Loko. In our interview, recorded at Natural Products Expo East 2017, Hunter discussed the remarkable rise (and notorious reputation) of Four Loko and why a focus on branding and merchandising was key to its success. Hunter also explained his belief that the natural food and beverage industry is “the most exciting space out there,” his role in reframing and positioning Koia as a brand first and foremost, and why entrepreneurs should look to align themselves with experienced, value-added investors and advisors. Also included in this episode: A discussion with Project NOSH senior staff reporter Meagan McGinnes about the FDA’s new guidance regarding peanut allergies and how food brands are reacting, innovating and commercializing. We chat with the folks behind Shackleton Whisky, a brand inspired by famed explorer Sir Ernest Shackleton. And in the latest edition of Elevator Talk, we caught up with Safir Jamal, the CMO of 1 Shot Protein, a brand of shots that contain 24g of clean protein per 3 oz. bottle. Show notes: 1:11 -- Reminders, Upcoming Deadlines -- Early registration is ending for NOSH Live and Brewbound Session. The room block is almost halfway full for BevNET Live. Sponsorship opportunities for the events are still available, including the Taste Radio gold package. BevNET’s new Media Kit is now available. Learn more about advertising with BevNET, Project NOSH and Brewbound and Taste Radio. 3:48 -- Pumpkin Spice Life -- ‘Tis the season for everything pumpkin spice. What started with lattes and cookies has become a phenomenon in which entire endcaps and aisles are dedicated to pumpkin spice products. Have we reached a saturation point with the flavor? The hosts discuss. 9:04 -- Interview: Chris Hunter, Founder/CEO Koia; Co-Founder, Phusion Projects -- In our interview with Hunter we discussed his background in the beverage business, navigating both the phenomenal success and intense public scrutiny of Four Loko, why he segued into the non-alcoholic beverages with Koia and how he sees the plant-based protein drink category evolving in the coming years. 29:18 -- Trendspotter: The FDA Wants More Kids Eating Peanuts -- Last month FDA Commissioner Scott Gottlieb released a statement regarding a new qualified health claim that early introduction of peanuts to certain high-risk infants may reduce risk of peanut allergy. We discussed the growing crises around peanut allergies, the FDA’s decision to issue the statement and opportunities for kids’ brands to leverage the new guidance in marketing and innovation strategies. 43:55 -- Interview -- Tim Jarvis and Jason Moore, Shackleton Whisky -- Scottish spirits company Whyte and Mackay recently announced the launch of Shackleton Whiskey, a brand inspired by famed explorer Sir Ernest Shackleton, who’s known for leading a series of British explorations to the Antarctic. We recently spoke with Tim Jarvis, an environmental explorer and global brand ambassador for Shackleton Whisky, who in 2013 led an authentic retracing of Shackleton’s journey, and Whyte & Mackay Single Malt Specialist Jason Moore about the new whisky and their role in its creation and launch on the market. 52:05 -- Elevator Talk: 1 Shot Protein is a brand of shots that contain 24g of clean protein per 3 oz. bottle. We recently caught up with the company’s CMO, Safir Jamal, who visited us at BevNET HQ. Brands in this episode: Koia, Four Loko, Not Your Father’s, Shackleton Whiskey, Hello Peanut, MyPeanut, 1 Shot Protein. For sponsorship opportunities, feedback and suggestions, contact podcast@bevnet.com.

FDA Commissioner Scott Gottlieb announced the agency had selected Apple, Verily, Samsung and Fitbit among the nine companies that will participate in its Pre-Certification Program at this years The MedTech Conference. The top FDA official leading the effort Bakul Patel spoke to Medtech Insight about their selection process and what’s next.

Well. I guess everyone knows by now what happened yesterday.FDA Commissioner Scott Gottlieb slapped cigarette companies in the face, announced to the world that Tobacco Harm Reduction does actually exist and is important, that e-cigarettes have huge potential and is giving the industry 4 extra years to prove that it is serious about saving lives and to becoming mature and professional.What the announcement didn't do, regardless of what you may have read on Facebook or saw on a YouTube video is repeal the deeming or save vaping.We have more time to prove ourselves. We'll discuss what needs to happen tonight at 11pm eastern at www.smokefreeradio.com on #sonoflibertyradio.My good friend Arnaud Dumas De Rauly will join us live to give some insights. Phones will be open, comes join in the conversation.